EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Seroprevalence of SARS-CoV-2 IgG and associated factors among people living with HIV over the first 12 months following the outbreak of COVID-19 in Burkina Faso, a sub-Saharan African country

Odilon D Kaboré iD, Armel Poda, Cheick Ahmed Ouattara, Fernand N Michodigni iD, Abdoul-Aziz Belem, Yacouba Sawadogo, Jacques Zoungrana, Lokman Galal, Clément Z Meda, Sylvain Godreuil, Abdoul-Salam Ouédraogo

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0286665 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Odilon D Kaboré und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bacteriology and Virology, Souro Sanou University Hospital, Bobo Dioulasso, Burkina Faso. Hauptthemen laut MEDLINE: COVID-19, Anti-HIV Agents, HIV Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Solidarity Fund for Innovative Projects of the French Ministry of Europe and Foreign Affairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to evaluate the seroprevalence of anti-SARS-CoV-2 IgG and factors associated with the infection among PLWHIV over the first 12 months following the outbreak of COVID-19 in Burkina Faso.

Design

A retrospective cross-sectional study of plasma samples collected from March 9, 2020, and March 8, 2021, at the outpatient HIV referral center, before the introduction of the SARS-CoV-2 vaccine in Burkina Faso.

Methods

Anti-SARS-CoV-2 IgG were detected in plasma using DS-ЕIA-ANTI-SARS-CoV-2-G (S) kit. Logistic regressions were used to compare SARS-CoV-2 specific immune responses between groups and within subgroups. Results and discussion A total of 419 plasma were subjected to serological diagnosis. None of the participants was vaccinated against COVID-19 during the period of sample collection, and 130 samples were positive for anti-SARS-CoV-2 IgG, giving a prevalence of 31.0% (95% CI 26.6–35.7). The median CD4 cell count was 661 cells/μL (IQR,422–928). Retailers had half the risk of being infected compared to housemaids with an OR of 0.49 ( p = 0.028, 95% CI 0.26–0.91). Likewise, the risk of infection was 1.69 times higher in patients on integrase inhibitors compared to that of patients on non-nucleoside reverse transcriptase inhibitors ( p = 0.020, 95% CI 1.09–2.63).

Conclusion

Our study reveals a high seroprevalence among PLWHIV to SARS-CoV-2 during the first year of the pandemic. In addition, PLWHIV on integrase inhibitors are 1.69 times more likely to be infected than PLWHIV on non-nucleoside inhibitors, and this observation remains an intriguing topic that still needs to be clarified.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Anti-HIV AgentsHIV InfectionsHumansCOVID-19 VaccinesBurkina FasoSARS-CoV-2Cross-Sectional StudiesRetrospective StudiesSeroepidemiologic StudiesAntibodies, ViralImmunoglobulin GDisease Outbreaks

Substanzen

COVID-19 VaccinesAntibodies, ViralImmunoglobulin GAnti-HIV Agents

Autor:innen und Institutionen

  • Department of Bacteriology and Virology, Souro Sanou University Hospital, Bobo Dioulasso, Burkina Faso.
  • Laboratory of Emerging and Re-emerging Pathogens, School of Health Sciences Nazi Boni University, Bobo Dioulasso, Burkina Faso.
  • Superior Institute of Health Sciences, Centre Hospitalier Universitaire Souro Sanou, NAZI BONI University, Bobo-Dioulasso, Burkina Faso.
  • Department of Infectious Diseases and Tropical Medicine, Souro Sanou University Hospital, Bobo Dioulasso, Burkina Faso.
  • Laboratoire de Bactériologie, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
  • Maladies Infectieuses et Vecteurs: Ecologie, Génétique, Evolution et Contrôle (MIVEGEC), Université de Montpellier-Institut de Recherche pour le Développement (IRD)-Centre National de la Recherche Scientifique (CNRS), M…

ORCID-Profile: Odilon D Kaboré, Fernand N Michodigni

Förderung

  • Solidarity Fund for Innovative Projects of the French Ministry of Europe and Foreign Affairs

Zitieren

APA

Kaboré, O. D., Poda, A., Ouattara, C. A., Michodigni, F. N., Belem, A. A., Sawadogo, Y., Zoungrana, J., Galal, L., Meda, C. Z., Godreuil, S., & Ouédraogo, A. S. (2023). Seroprevalence of SARS-CoV-2 IgG and associated factors among people living with HIV over the first 12 months following the outbreak of COVID-19 in Burkina Faso, a sub-Saharan African country. PLOS ONE. https://doi.org/10.1371/journal.pone.0286665

Vancouver

Kaboré OD, Poda A, Ouattara CA, Michodigni FN, Belem AA, Sawadogo Y, et al. Seroprevalence of SARS-CoV-2 IgG and associated factors among people living with HIV over the first 12 months following the outbreak of COVID-19 in Burkina Faso, a sub-Saharan African country. PLOS ONE. 2023. doi:10.1371/journal.pone.0286665

BibTeX
@article{Kabor2023,
  author = {Kaboré, Odilon D and Poda, Armel and Ouattara, Cheick Ahmed and Michodigni, Fernand N and Belem, Abdoul-Aziz and Sawadogo, Yacouba and Zoungrana, Jacques and Galal, Lokman and Meda, Clément Z and Godreuil, Sylvain and Ouédraogo, Abdoul-Salam},
  title = {Seroprevalence of SARS-CoV-2 IgG and associated factors among people living with HIV over the first 12 months following the outbreak of COVID-19 in Burkina Faso, a sub-Saharan African country},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0286665}
}
Kostenlos starten →